Information Provided By:
Fly News Breaks for February 8, 2016
ATHN
Feb 8, 2016 | 06:04 EDT
Topeka analyst Eugene Mannheimer upgraded athenahealth to Buy citing valuation. The analyst views the risk/reward as more favorable at current share levels and believes the company is executing well on its ambulatory targets. Mannheimer has a $160 price target for the shares.
News For ATHN From the Last 2 Days
There are no results for your query ATHN